PINEAL PARENCHYMAL NEOPLASM MALIGNANT

This adverse event was reported 17 times

These drugs are most commonly taken by patients reporting PINEAL PARENCHYMAL NEOPLASM MALIGNANT:

# Drug Count
0 CARBOPLATIN 4
1 ETOPOSIDE 3
2 TEMOZOLOMIDE 3
3 DEXAMETHASONE 2
4 DEXAMETHASONE 1.5 MG 2
5 FILGRASTIM 2
6 IFOSFAMIDE 2
7 IFOSFAMIDE FOR INJECTION 2
8 THALIDOMIDE 2
9 TOPOTECAN 2
See all common drugs associated with PINEAL PARENCHYMAL NEOPLASM MALIGNANT

PINEAL PARENCHYMAL NEOPLASM MALIGNANT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BUPROPION HYDROBROMIDE 1 0.0017
1 PLERIXAFOR 1 0.0007
2 TAZEMETOSTAT 1 0.0006
3 ALENDRONATE SODIUM AND CHOLECALCIFEROL 1 0.0004
4 TOPOTECAN 2 0.0003
5 IVABRADINE 1 0.0001
6 TEMOZOLOMIDE 3 0.0001
7 PHYTONADIONE 1 0.0001
8 THIOTEPA 1 0.0001
9 IFOSFAMIDE FOR INJECTION 2 0.0001
See all drugs enriched for association with PINEAL PARENCHYMAL NEOPLASM MALIGNANT

PINEAL PARENCHYMAL NEOPLASM MALIGNANT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hematopoietic Stem Cell Mobilizer [EPC] 1 0.0007
1 Vitamin K [EPC] 1 0.0001
2 GLP-2 Analog [EPC] 1 0.0001
3 Topoisomerase Inhibitor [EPC] 5 0.0001
4 Progesterone [EPC] 1 0.0000
5 Provitamin D2 Compound [EPC] 1 0.0000
6 Phenothiazine [EPC] 1 0.0000
7 Alkylating Drug [EPC] 5 0.0000
8 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
9 Platinum-based Drug [EPC] 4 0.0000
See all drug classes enriched for association with PINEAL PARENCHYMAL NEOPLASM MALIGNANT